To compare the effects of intensive resistance training of the lumbal extensors with usual care as provided and prescribed by the GP, for patients with chronic a-specific low back pain.
ID
Source
Brief title
Condition
- Musculoskeletal and connective tissue disorders NEC
- Changes in physical activity
- Lifestyle issues
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- pain
- fear of movement
- level of daily-activities, participation in work, sports and hobbies
Secondary outcome
- maximum isometric liftforce
Background summary
Low back pain is a common disorder. 60 to 90% of the population suffers from
low back pain at least once. Every year 5% of the population has to deal with
it and 3% of the patients seen by the GP annaually suffers from low back
complaints. Most low back pain is of non-specific origin. According to
literature only 10% of all low back pain has a specific origin and 90% is
characterized as a-specifc low back pain. Part of these patients deal with
chronic complaints, i.e. low back pain which is persistent for more than 3
months. These chronic patients are responsible for a large share in all costs
(medical, work loss) associated with low back pain.
In 1991 1.7% of the BNP was used for care of patients suffering from low
backpain.
The Sports Medicine and Health Care department of the St. Annahospital has been
treating patients with chronic a-specific low back pain with intensive
resistance-exercises of the lumbal extensors for two years now. These patients
receive no other treatments in the hospital. A lower back resistance machine,
specifically designed for this purpose, is in use for this treatment. The
sports physicains prescribing this treatment and the physiotherapists who are
applying this treatment speak of favorable results using this treatment.
However, scientific evidence supporting this treatment is lacking. Therefore it
would be valuable to compare this intensive lower back resistance training with
the usual care provided by the GP to see if this treatment has a surplus value
over usual care provided by the GP.
If the study shows that the treatment of intensive resistance-training is more
effective than usual care provided by the GP, it is possible for the GP to add
this kind of treatment to his treatment-options. If the intervention of
restistance-training doesn't show to be more effective, the treatment of these
in the St. Annahospital has to be adapted.
Study objective
To compare the effects of intensive resistance training of the lumbal extensors
with usual care as provided and prescribed by the GP, for patients with chronic
a-specific low back pain.
Study design
A randomised controlled trial (RCT). There will be a baseline-measurement prior
to randomisation. Effects of the different interventions will be measured at
three months after starting treatment.
Intervention
After inclusion and baseline measurements procedures are completed, each
patient will be allocated by means of randomisation to a group which receives
intensive resistance-training of the lumbal extensors with no other treatments
applied, or to a group that receives the usual care as prescribed and provided
by the GP. After three months there will be a follow-up measurement.
Study burden and risks
Before treatment there will be a baseline measurement. This will take 90
minutes, including the randomisation procedure. One group will receive usual
care (control group), the other group will receive intensive
resistance-training (intervention-group). This resistance training is done once
a week for 13 weeks, each training-session lasting 15 minutes. After three
months there will be a follow-up measurement, which also takes 90 minutes.
The study isn't associated with any other risks for the participant compared
with usual physical therapy.
Bogardeind 2
5664 EH Geldrop
Nederland
Bogardeind 2
5664 EH Geldrop
Nederland
Listed location countries
Age
Inclusion criteria
Patients:
- with low back pain with a minimum duration of three months
- without specific medical abnormalities for these complaints
- in which these complaints have been apparent for at least three months directly prior to this study. The intensity and extent of these complaints may vary within these three months.
- who can understand, read en speak the dutch language
- who have a minimum age of 18 years
- a maximum score of 90 points on the QBPDS
- VAS painscore * 2
Exclusion criteria
Persons with:
- lumbosacral radiculair syndrom
- Herniated disc complaints at any vertebrated level
- wervelmetastasen
- spinal stenosis
- recessus lateralis stenosis
- spondylolisthesis
- spondylitis ankylopoetica
- osteoporotic vertebral fracture(s)
- active M. Scheuermann
- fracture which interferes with the treatment or has a causal relationship with the back complaints
- a trauma whtich interferes with the treatment or has a causal relationship with the back complaints
- instabale angina pectoris or any other heart and vascular conditions interfering with the treatment
- poorly controlled hypertension (systolic >160 mmHg, diastolic > 105 mmHg)
- poorly controlled diabetes
- poorly controlled epilepsy
- breathing complaints at rest
- poor physical status other than lower back complaints interfering with the proposed treatment
- severe neurological degenerative diseases which interfere with the proposed treatment or have a causal relationship with the lower back complaints
- active reumatic diseases which interfere with the proposed treatment or have a causal relationship with the lower back complaints
- other diagnosed conditions of neurologic, orthopedic or internal character which interfere with the proposed treatment or have a causal relationship with the lower back complaints
- who are pregnant and are limited to perform the necessary movements inherent to the back extensor training due to physical changes caused by pregnancy
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL13281.015.06 |